Apr 13, 2021
Dr. Nicole Bashall, an anesthesiology resident at Penn State Health Milton S. Hershey Medical Center, was honored in April 2021 as part of the Exceptional Moments in Teaching program of Penn State Health and Penn State College of Medicine.
Apr 2, 2021
Women who were pioneers as faculty and researchers at the College of Medicine and Milton S. Hershey Medical Center told their stories as part of a full-day symposium, "A Celebration of Women in Science."
Mar 23, 2021
New research by a team of Penn State scientists – including Penn State College of Medicine professor Kristin Eckert – shows that the elevated mutation rate in sequences of DNA that can fold into shapes other than the classic double helix plays a major role in determining regional variation in mutation rates across the genome.
Zinc oxide topical ointment – commonly used to treat conditions like diaper rash or eczema – may be the best way to provide relief from irritation caused by wearing facemasks, according to researchers from the Department of Dermatology.
A research team from Penn State Cancer Institute and the Department of Surgery at Penn State College of Medicine led by surgical resident Dr. Elizabeth Olecki determined that final pathology results after surgical resection may be influencing providers when they counsel patients on further pancreatic cancer treatment.
Mar 4, 2021
Dr. Michelle Fischer is featured for March in the “Exceptional Moments in Teaching” program.
Feb 22, 2021
Results from studies by researchers at Penn State Neuroscience Institute suggest that a new type of drug may provide a “second honeymoon” for patients with very advanced Parkinson's disease.
Jan 29, 2021
Natasha Renee Burse is not a stranger to competition. She went from sprinting to the finish line of races as a Division I track and field athlete to striving to […]
Jan 22, 2021
Dr. Monika Joshi, associate professor of medicine at Penn State College of Medicine and medical oncologist at Penn State Cancer Institute, has been named chief scientific officer of the Big Ten Cancer Research Consortium.
Jan 11, 2021
Some metastatic breast cancer patients are taking smaller doses of opioid prescriptions over decreased amounts of time, according to Penn State College of Medicine and Penn State Cancer Institute researchers. They say the results indicate that clinicians may be more aware of the negative impacts of prolonged opioid use and are seeking alternative pain management options.
